Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This was a single‐center, multiple‐dose, randomized, double‐blind, placebo‐controlled, positive‐controlled, twelve sequence, 3‐period cross‐over study to investigate the effect of balovaptan on the QTc interval in healthy subjects.
Epistemonikos ID: 3619ed9209da62efcb5902c4ed36209bcfcf1cd9
First added on: May 21, 2024